Tandem Diabetes Care, founded in 2006, is a medical device manufacturer that develops automated insulin delivery systems. The company's technical work centers on predictive algorithm development and CGM integration, applying artificial intelligence to automate insulin delivery for diabetes management.
Its products include the Tandem Mobi system and t:slim X2 pump, both powered by Control-IQ+ technology. This proprietary predictive algorithm with AutoBolus automates insulin delivery to improve glucose control, representing a key application of AI in medical devices.
Headquartered in San Diego, California, Tandem Diabetes Care operates within the healthcare and medical device industries, with a human-centered design approach focused on patient outcomes and comprehensive support services.
